At close: December 20 at 4:00:00 PM EST
After hours: December 20 at 7:44:46 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | -- |
Avg. Estimate | -5.5 | 0 | -23.75 | 0 |
Low Estimate | -5.5 | 0 | -23.75 | 0 |
High Estimate | -5.5 | 0 | -23.75 | 0 |
Year Ago EPS | -8.25 | -7.5 | -28.5 | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | -- | 0.00% | 0.00% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | -8.25 | -8.5 | -4.75 | -5.25 |
EPS Actual | -8.25 | -7.5 | -10.75 | -6.81 |
Difference | 0 | 1 | -6 | -1.56 |
Surprise % | 0.00% | 11.76% | -126.32% | -29.71% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -5.5 | 0 | -23.75 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | -- | -- | -- |
Up Last 30 Days | 1 | -- | -- | -- |
Down Last 7 Days | -- | -- | 1 | -- |
Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
TOVX | 33.33% | -- | 16.67% | -- |
S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
Maintains | Maxim Group: Buy to Buy | 11/13/2024 |
Related Tickers
ATHA Athira Pharma, Inc.
0.5760
+5.11%
KPRX Kiora Pharmaceuticals, Inc.
3.2700
+1.55%
ADTX Aditxt, Inc.
0.1861
-17.65%
AIM AIM ImmunoTech Inc.
0.1900
-0.58%
SPRC SciSparc Ltd.
0.2133
-0.19%
TRAW Traws Pharma, Inc.
5.02
-8.56%
GRI GRI Bio, Inc.
0.7400
-3.90%
XBIO Xenetic Biosciences, Inc.
4.2900
+4.63%
AZTR Azitra, Inc.
0.4150
+5.01%
PBLA Panbela Therapeutics, Inc.
0.3250
+3.17%